UMC science gets personal

Research / 16 March 2023

The Research corner film series puts UMC pharmacovigilance scientists in the spotlight as they discuss their research and its implications for pharmacovigilance science.

We’re pleased to announce the first in a new series of short films, presenting UMC’s research to our global audience, in a new format. Research Corner – UMC’s Science in the Spotlight puts our research and researchers in focus, with each episode in the series featuring a recently completed study: what was investigated and why, what were the findings, and what does it mean for pharmacovigilance.

For this first episode we teamed up with Daniele Sartori, pharmacovigilance scientist at UMC and lead author of a paper on the evidence base and features of ADR reports that are used to support signals. Daniele sat down with us for a short interview to describe his research and assist us in producing some visualisations of his work. The finished film can be seen below.

Daniele had this to say about the new initiative: "From paper to film. The Research Corner captured my study from a different angle, personal, but to the point. As a researcher I'm not used to being in the limelight but overall, it was a great experience that will help to expand the outreach of my research to a wider audience.”

The aim of this series is to promote our research in engaging bite-size chunks, giving the viewer an overview of the work and the people behind it, as a complement to more in-depth content on our channels and the academic papers themselves. We’re excited to see who’s next in the Research Corner series, so look out for future editions on UMC’s channels.

Read more:

D Sartori, “Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature”, Drug Safety, 2023.

Research poster on the review.

Matthew Barwick
Communications officer & video producer, UMC

You may also like

Looking beyond age to understand adverse reaction risk in older patients

When it comes to pharmacovigilance in older patients, age alone is insufficient as a measure of adverse reaction risk. Here is what we should consider instead.

Research / 13 May 2024

Updating our approach to study adverse reactions

The traditional “drug-event combination” approach is too simplistic for complex side effects such as behavioural changes. We must adjust our methodology to address this intricacy.

Research / 29 May 2024

When medicines change our behaviour – New podcast out now

Adverse effects to medicines are not just physical in nature, but can manifest as behavioural side-effects too. How do we diagnose and treat these complex ADRs?

Research / 02 May 2024

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more